Crossmark

Assessment and management of obesity and metabolic syndrome in children with CKD stages 2–5 on dialysis and after kidney transplantation—clinical practice recommendations from the Pediatric Renal Nutrition Taskforce

Crossref DOI link: https://doi.org/10.1007/s00467-021-05148-y

Published Online: 2021-08-10

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stabouli, Stella https://orcid.org/0000-0001-9843-8198
Polderman, Nonnie

Nelms, Christina L.

Paglialonga, Fabio

Oosterveld, Michiel J. S.

Greenbaum, Larry A.

Warady, Bradley A.

Anderson, Caroline

Haffner, Dieter

Desloovere, An

Qizalbash, Leila

Renken-Terhaerdt, José

Tuokkola, Jetta

Walle, Johan Vande

Shaw, Vanessa

Mitsnefes, Mark

Shroff, Rukshana
License Information

Text and Data Mining valid from 2021-08-10

Version of Record valid from 2021-08-10
More Information

Article History

Received: 3 April 2021

Revised: 4 May 2021

Accepted: 18 May 2021

First Online: 10 August 2021

Declarations

:

: The authors declare no competing interests.

: The Pediatric Renal Nutrition Taskforce wishes to confirm that Vitaflo has not influenced the development or content of these Clinical Practice Recommendations. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.

Document is current

Any future updates will be listed below